Literature DB >> 32109517

Association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in patients with type 2 diabetes.

Yongze Zhang1, Ximei Shen1, Lanlan He2, Fengying Zhao1, Sunjie Yan3.   

Abstract

AIM: This study aimed to investigate the association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in type 2 diabetes mellitus.
METHODS: A total of 1794 patients (937 men and 857 women) with type 2 diabetes, with a mean age of 60.22 years, were enrolled for a cross-sectional study; of these, 183 patients were enrolled for a follow-up study with a median follow-up of 2.7 years. All participants underwent nerve conduction studies and muscle mass index (ASM/HT2) measurements. The composite Z scores for the sensory nerve conduction velocity (SCV) and the motor nerve conduction velocity (MCV) were calculated. The changes in ASM/HT2, SCV, and MCV were calculated from the measurements nearly 2 years apart and classified into three groups: a decrease in ASM/HT2 of >3%, a minor change within ±3%, and an increase in ASM/HT2 of >3%.
RESULTS: The ASM/HT2 of men was positively associated with the composite Z scores of MCV and SCV, and sarcopenia highly correlated with DPN after adjusting for confounding factors. The optimal cutoff point for ASM/HT2 that indicated DPN was 7.09 kg/m2. Furthermore, increases in ASM/HT2 independently predicted a greater benefit of MCV and SCV increment outcomes, whereas a minor change in ASM/HT2 only significantly associated with lower benefit in terms of SCV increment. However, this phenomenon was not observed in women.
CONCLUSIONS: Sarcopenia and DPN exhibited a close association. The increased muscle mass improved the partial MCVs and SCVs. However, a sex-related discrepancy was observed in this phenomenon.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Muscle mass; Nerve conduction velocity; Peripheral neuropathy; Sarcopenia; Type 2 diabetes

Year:  2020        PMID: 32109517     DOI: 10.1016/j.diabres.2020.108096

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Relationship between peripheral neuropathy and cognitive performance in the elderly population.

Authors:  Yu-Jen Lin; Tung-Wei Kao; Wei-Liang Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

2.  Association of decreased muscle mass with reduced bone mineral density in patients with Graves' disease.

Authors:  Yongze Zhang; Yuzhen Ke; Lingning Huang; Ximei Shen; Sunjie Yan; Fengying Zhao; Yimei Li; Yuxi Lin
Journal:  Endocrine       Date:  2022-01-22       Impact factor: 3.633

3.  The Association Between Diabetes Mellitus and Risk of Sarcopenia: Accumulated Evidences From Observational Studies.

Authors:  Yu-Shun Qiao; Yin-He Chai; Hong-Jian Gong; Zhiyessova Zhuldyz; Coen D A Stehouwer; Jian-Bo Zhou; Rafael Simó
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

4.  Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes.

Authors:  Feihui Zeng; Lingning Huang; Yongze Zhang; Xinyu Hong; Suiyan Weng; Ximei Shen; Fengying Zhao; Sunjie Yan
Journal:  J Diabetes Res       Date:  2022-01-24       Impact factor: 4.011

5.  Association between sarcopenia and the severity of diabetic polyneuropathy assessed by nerve conduction studies in Japanese patients with type 2 diabetes mellitus.

Authors:  Kentaro Mikura; Eriko Kodama; Tatsuya Iida; Hideyuki Imai; Mai Hashizume; Yasuyoshi Kigawa; Rie Tadokoro; Chiho Sugisawa; Kei Endo; Toru Iizaka; Fumiko Otsuka; Shoichiro Nagasaka
Journal:  J Diabetes Investig       Date:  2022-03-21       Impact factor: 3.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.